Literature DB >> 2141044

Synthesis of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine by an enriched preparation of the human lung mast cell.

M Triggiani1, W C Hubbard, F H Chilton.   

Abstract

Our study has examined the synthesis of platelet activating factor (PAF; 1-0-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and of structurally related molecules by an enriched preparation (greater than 70%) of the human lung mast cell (HLMC) in response to immunologic stimulation. Upon activation with anti-IgE, HLMC incorporated exogenously provided acetate into a phospholipid that migrated with authentic PAF on TLC. The formation of this product in HLMC occurred concomitantly with histamine and leukotriene C4 release. Further analysis of this phospholipid revealed that 1-acyl-2-acetyl-sn-glycero-3-phosphocholine (GPC) and not 1-alkyl-2-acetyl-GPC was the major 1-radyl-2-acetyl-GPC subclass formed during cell activation. The presence of 1-alkyl-2-acetyl-GPC was confirmed by negative ion chemical ionization mass spectrometry. In addition to this product, anti-IgE-stimulated HLMC synthesized relatively small quantities of another 2-acetylated phospholipid migrating on TLC between phosphatidylcholine and phosphatidylinositol. The chromatographic characteristics of this product suggested that it is a subclass of 1-radyl-2-acetyl-sn-glycero-3-phosphoethanolamine. The catabolism of both 1-acyl-2-acetyl-GPC and 1-alkyl-2-acetyl-GPC was next examined to determine if the predominant formation of 1-acyl-2-acetyl-GPC over 1-alkyl-2-acetyl-GPC were metabolized by the HLMC at similar rates. There was, however, a qualitative difference in the metabolic products derived from the two phospholipids. 1-Alkyl-2-acetyl-GPC was rapidly inactivated by removal of the acetate moiety at the sn-2 position followed by rapid reacylation with arachidonate. By contrast, 1-acyl-2-acetyl-GPC was catabolized mainly by removal of the fatty acyl moiety at the sn-1 position. These data demonstrate the natural occurrence of PAF and at least two structurally similar molecules in anti-IgE stimulated HLMC. Furthermore, an analog containing an ester linkage at the sn-1 position, 1-acyl-2-acetyl-GPC, appears to be the major acetylated product synthesized under these conditions.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2141044

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Platelet-activating factor synthesis by peritoneal mast cells and its inhibition by two quinoline-based compounds.

Authors:  C M Hogaboam; D Donigi-Gale; T S Shoupe; E Y Bissonnette; A D Befus; J L Wallace
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

2.  The role of platelet-activating factor and peptidoleukotrienes in the vascular changes of rat passive anaphylaxis.

Authors:  S Fernández-Gallardo; M A Gijón; C García; V Furio; F T Liu; M Sánchez Crespo
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

Review 3.  Structural and (patho)physiological diversity of PAF.

Authors:  R N Pinckard; D S Woodard; H J Showell; M J Conklyn; M J Novak; L M McManus
Journal:  Clin Rev Allergy       Date:  1994

4.  Role of platelet-activating factor in pancreatitis-associated acute lung injury in the rat.

Authors:  W Zhou; M O McCollum; B A Levine; M S Olson
Journal:  Am J Pathol       Date:  1992-04       Impact factor: 4.307

5.  Factors that influence the proportions of platelet-activating factor and 1-acyl-2-acetyl-sn-glycero-3-phosphocholine synthesized by the mast cell.

Authors:  M Triggiani; A N Fonteh; F H Chilton
Journal:  Biochem J       Date:  1992-09-01       Impact factor: 3.857

6.  Characterization of platelet-activating factor synthesized by normal and granulocyte-macrophage colony-stimulating factor-primed human eosinophils.

Authors:  M Triggiani; R P Schleimer; K Tomioka; W C Hubbard; F H Chilton
Journal:  Immunology       Date:  1992-12       Impact factor: 7.397

7.  Potential angiogenic role of platelet-activating factor in human breast cancer.

Authors:  G Montrucchio; A Sapino; B Bussolati; G Ghisolfi; S Rizea-Savu; L Silvestro; E Lupia; G Camussi
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

8.  Study of the effector mechanism involved in the production of haemorrhagic necrosis of the small intestine in rat passive anaphylaxis.

Authors:  M I Pellón; A A Steil; V Furió; M Sánchez Crespo
Journal:  Br J Pharmacol       Date:  1994-08       Impact factor: 8.739

Review 9.  Human heart as a shock organ in anaphylaxis.

Authors:  Gianni Marone; Arturo Genovese; Gilda Varricchi; Francescopaolo Granata
Journal:  Allergo J Int       Date:  2014-03-19

10.  Antigen-induced generation of lyso-phospholipids in human airways.

Authors:  F H Chilton; F J Averill; W C Hubbard; A N Fonteh; M Triggiani; M C Liu
Journal:  J Exp Med       Date:  1996-05-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.